BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35957656)

  • 1. Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA).
    Farris KB; Cadwallader T; Farley J; Gatwood K; Mackler E; Gatwood J
    Explor Res Clin Soc Pharm; 2022 Sep; 7():100163. PubMed ID: 35957656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions.
    Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J
    J Oncol Pharm Pract; 2024 Mar; 30(2):342-353. PubMed ID: 37113049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
    Lam MS; Cheung N
    J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma.
    Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J
    JCO Oncol Pract; 2022 Sep; 18(9):e1475-e1483. PubMed ID: 35700416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photo elicitation, an approach to better understanding the patient experience with OAAs: pilot study and future implications.
    Manojlovich M; Blok A; Wright N; Azhari E; Farris KB; Friese CR; Mackler E; Titler M; Byrnes M
    Support Care Cancer; 2023 Oct; 31(12):652. PubMed ID: 37878093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Video reflexive ethnography as an intervention to improve oral anti-cancer agent patient education: A pilot study.
    Manojlovich M; Rizvi-Toner A; DasGupta R; Farris K; Friese C; Kostoff D; Mackler E; Millisor V; Titler MG
    PEC Innov; 2023 Dec; 2():100148. PubMed ID: 37214518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.
    Kaye DR; Wilson LE; Greiner MA; Spees LP; Pritchard JE; Zhang T; Pollack CE; George D; Scales CD; Baggett CD; Gross CP; Leapman MS; Wheeler SB; Dinan MA
    J Geriatr Oncol; 2022 Jun; 13(5):614-623. PubMed ID: 35125336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications.
    Stanton-Robinson C; Al-Jumaili AA; Jackson A; Catney C; Veach S; Witry MJ
    J Am Pharm Assoc (2003); 2018; 58(4S):S120-S124. PubMed ID: 29891173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient symptoms, self-management, and unscheduled healthcare use during the first 6 months of targeted oral anticancer agent therapy: protocol for a mixed-methods US study.
    Rizvi-Toner A; Coe AB; Friese CR; Manojlovich M; Wallner L; Farris KB
    BMJ Open; 2024 Feb; 14(2):e081375. PubMed ID: 38355181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-Led Discharge Medication Counseling and its Corresponding Impact on Medication Adherence and Hospital Readmission Rates.
    Cunningham S; Kinsey JD
    Innov Pharm; 2020; 11(3):. PubMed ID: 34007627
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient self-management and pharmacist-led patient self-management in Hong Kong: a focus group study from different healthcare professionals' perspectives.
    Wong FY; Chan FW; You JH; Wong EL; Yeoh EK
    BMC Health Serv Res; 2011 May; 11():121. PubMed ID: 21609422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists' and Patients' Perspectives.
    Ali EE; Chan SSL; Poh HY; Susanto YA; Suganya T; Leow JL; Pang CK; Chew L; Yap KY
    J Med Syst; 2019 Feb; 43(3):63. PubMed ID: 30726518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.
    Spees LP; Wheeler SB; Jackson BE; Baggett CD; Wilson LE; Greiner MA; Kaye DR; Zhang T; George D; Scales CD; Pritchard JE; Leapman M; Gross CP; Dinan MA
    Cancer Med; 2021 Oct; 10(19):6653-6665. PubMed ID: 34480518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.
    Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Jiménez RR; Peinado II; Herranz-Alonso A; Sanjurjo-Sáez M
    Am J Health Syst Pharm; 2020 Aug; 77(17):1393-1402. PubMed ID: 32620958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physician-pharmacist collaborative care model to prevent opioid misuse.
    Lagisetty P; Smith A; Antoku D; Winter S; Smith M; Jannausch M; Mi Choe H; Bohnert ASB; Heisler M
    Am J Health Syst Pharm; 2020 May; 77(10):771-780. PubMed ID: 32315401
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.